Galera Therapeutics, Inc. (GRTX)
OTCMKTS: GRTX · Delayed Price · USD
0.135
+0.010 (8.00%)
Jul 2, 2024, 3:56 PM EDT - Market closed
Galera Therapeutics Market Cap
Galera Therapeutics has a market cap or net worth of $7.34 million as of July 2, 2024. Its market cap has decreased by -94.20% in one year.
Market Cap
7.34M
Enterprise Value
146.14M
1-Year Change
-94.20%
Ranking
n/a
Category
Stock Price
$0.14
Market Cap Chart
Since November 7, 2019, Galera Therapeutics's market cap has decreased from $292.30M to $7.34M, a decrease of -97.49%. That is a compound annual growth rate of -55.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2024 | 7.90M | - |
| Dec 29, 2023 | 7.90M | -81.41% |
| Dec 30, 2022 | 42.50M | -64.99% |
| Dec 31, 2021 | 121.40M | -52.45% |
| Dec 31, 2020 | 255.30M | -21.81% |
| Dec 31, 2019 | 326.50M | 11.70% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 868.98B |
| Novo Nordisk | 645.53B |
| UnitedHealth Group | 459.94B |
| Johnson & Johnson | 350.59B |
| Merck & Co. | 324.25B |
| AbbVie | 301.83B |
| AstraZeneca | 241.72B |
| Novartis AG | 208.42B |